STEVEN B NEWMAN MD NPI 1750370755

NPI Details

Steven B Newman, MD is a medical oncology internal medicine in Naples, FL with 49 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Steven B Newman, MD NPI is 1750370755. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: TUFTS UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1977

The provider's business location address is:

6360 PINE RIDGE RD
SUITE 201
NAPLES, FL
ZIP 34119-907
Phone: (239) 353-6636
Fax: (239) 354-1865

The NPI 1750370755 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, octreotide, depot form for intramuscular injection, 1 mg (HCPCS:J2353)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Uric acid level, blood (HCPCS:84550)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Protein measurement, serum (HCPCS:84165)
• Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Magnesium level (HCPCS:83735)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Automated urinalysis test (HCPCS:81003)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Folic acid level, serum (HCPCS:82746)
• Drawing of blood for a medical problem (HCPCS:99195)
• Red blood count, automated test (HCPCS:85045)
• Red blood count, manual test (HCPCS:85044)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Testosterone (hormone) level, total (HCPCS:84403)
• Phosphate level (HCPCS:84100)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Urinalysis, manual test (HCPCS:81002)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS:G0328)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Erythropoietin (protein) level (HCPCS:82668)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Hepatitis b core antibody (igm) measurement (HCPCS:86705)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)

The enumeration date for this NPI number is 10/21/2005 and was last updated on 8/11/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.